首页> 外文期刊>Pathophysiology of haemostasis and thrombosis >Quantification of antithrombin isoform proportions in plasma samples of healthy subjects, sepsis patients, and in antithrombin concentrates.
【24h】

Quantification of antithrombin isoform proportions in plasma samples of healthy subjects, sepsis patients, and in antithrombin concentrates.

机译:在健康受试者,脓毒症患者和抗凝血酶浓缩物中血浆样品中抗凝血酶同工型比例的定量。

获取原文
获取原文并翻译 | 示例
           

摘要

Antithrombin (AT) circulates in plasma in two isoforms, AT-alpha (90-95%) and AT-beta (5-10%). AT isoform proportions were measured in plasma samples of 17 healthy subjects and 26 posttraumatic or postoperative septic patients, as well as in 4 commercially available AT concentrates. Total AT was immune-purified from plasma and concentrates. Micellar electrokinetic chromatography was used to analytically separate and quantify the isoforms. Compared with plasma samples of healthy donors, septic plasmas revealed significantly reduced AT activity (p < 0.001) and beta-isoform content (p < 0.05). AT-beta correlated inversely with urea and creatinine serum concentrations (p < 0.01), indicating a relationship between better renal function and higher beta-isoform content. beta-Isoform neither correlated with age, gender, and 28-day mortality, nor with plasma concentrations of various inflammatory and organ function parameters. The commercial AT concentrate, which is equivalent to the current WHO standard, had an AT-beta content close to that found in plasma of healthy subjects. The availability of this novel quantitative AT isoform assay allows, for the first time, a closer look at the role of AT isoforms in hemostasis and sepsis pathophysiology.
机译:抗凝血酶(AT)在血浆中以两种亚型循环,即AT-alpha(90-95%)和AT-beta(5-10%)。在17名健康受试者和26名创伤后或术后败血病患者的血浆样品中,以及在4种市售的AT浓缩物中,测量了AT同工型比例。从血浆和浓缩液中免疫纯化了总AT。胶束电动色谱法用于分析分离和定量同工型。与健康供体的血浆样品相比,败血性血浆显示AT活性(p <0.001)和β-亚型含量(p <0.05)明显降低。 AT-β与尿素和肌酐的血清浓度呈负相关(p <0.01),表明更好的肾功能和更高的β-亚型含量之间存在关联。 β异构体既不与年龄,性别和28天死亡率相关,也不与各种炎症和器官功能参数的血浆浓度相关。相当于当前WHO标准的商业化AT浓缩物的AT-beta含量接近健康受试者血浆中的含量。这种新颖的定量AT异构体测定的可用性首次使我们可以更仔细地了解AT异构体在止血和败血症病理生理中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号